Tiny Graphene Dots Push Breath Sensors to the Edge of Lung Cancer Detection

Imagine a screening test for lung cancer that asks you to do nothing more strenuous than exhale into a small device. That vision moved a step closer to reality with a new study published in the Journal of Nanoparticle Research, in which researchers at the University of Madras and collaborating institutions in Tamil Nadu, India, report a chemiresistive gas sensor built from graphene quantum dots that can detect volatile organic compounds linked to lung cancer at extraordinarily low concentrations, all at room temperature. The work, led by P. Sarumathi Alias Ishwariya and C. Venkateswaran, is less about a finished clinical product and more about a rigorous interrogation of where the sensing limits of this nanomaterial actually lie, and the answer turns out to be remarkably encouraging.

The biological premise behind the sensor is well established. Tumours rewire cellular metabolism, and the chemical fingerprints of that rewiring escape the body in exhaled breath as volatile organic compounds, or VOCs. Previous studies, including work cited by the team from breath research literature, have shown that patients with lung cancer exhale altered profiles of compounds such as isopropyl alcohol compared with healthy individuals. The clinical appeal is obvious: breath testing is non-invasive, painless and potentially cheap enough for repeated population-level screening. The technical challenge, however, is that these biomarkers circulate at parts-per-million concentrations and below, demanding sensors that combine extreme sensitivity with the ability to operate without heating the sensing material to hundreds of degrees Celsius, as many conventional metal oxide sensors require.

The Indian team’s answer to that challenge begins with the sensing material itself. Graphene quantum dots, or GQDs, are nanoscale fragments of graphene, typically only a few nanometres across, that retain much of graphene’s exceptional electrical conductivity while gaining new properties from their tiny size and abundant edge sites. The researchers synthesised their GQDs using a pyrolysis-reduction method, a process that involves heating a carbon precursor to break it down into small graphitic domains and then chemically reducing the resulting material. This route is attractive because it is relatively simple and scalable compared with more exotic synthesis techniques, and it produces dots decorated with oxygen-containing functional groups on their surfaces, which turn out to be the secret ingredient for gas sensing.

Before any sensing could happen, the team had to confirm exactly what they had made, and they did so with a standard battery of characterisation techniques. Ultraviolet-visible spectroscopy revealed the optical absorption signature of the quantum dots, while photoluminescence measurements confirmed the characteristic blue fluorescence that GQDs are known for, a property tied to their quantum confinement and surface states. Transmission electron microscopy provided the most direct evidence, imaging the dots directly and confirming their nanometre-scale dimensions. These measurements matter because the sensing performance of GQDs depends critically on their size, their degree of carbonisation and the density of functional groups on their surface, so knowing the material’s structure is essential to understanding why it behaves the way it does when gas molecules land on it.

The sensor architecture is equally considered. The researchers fabricated an interdigitated electrode array, the comb-like metallic structure onto which the GQDs are deposited and across which electrical resistance is measured, using ultraviolet lithography with a dry film photoresist, or DFR. This is a notable choice. Traditional photolithography relies on liquid photoresists and cleanroom processes that are expensive and generate significant chemical waste. Dry film photoresist, by contrast, comes as a solid laminate that is applied, exposed and developed with far less fuss, and it has gained popularity in microfluidics and sensor prototyping precisely because it enables rapid, environmentally friendlier fabrication without sacrificing patterning precision. For a technology whose ultimate ambition is cheap point-of-care diagnostics, keeping the manufacturing simple and low-cost is not a cosmetic detail; it is central to the design philosophy.

The sensing mechanism itself is a story of electrons and adsorbed molecules. In a chemiresistive sensor, the quantity being measured is simply the electrical resistance of the sensing film. When oxygen molecules from ambient air adsorb onto the surface of the GQDs, they capture electrons from the material, forming a surface layer of adsorbed oxygen species and modulating the conductivity of the film. When a target VOC such as isopropyl alcohol arrives, it reacts with these adsorbed oxygen species, releasing captured electrons back into the carbon network and shifting the resistance in a measurable way. Because GQDs present an enormous surface-area-to-volume ratio, with functionalised edges offering abundant adsorption sites, even a small number of gas molecules produces a detectable electrical change. The oxygen functional groups identified in prior theoretical and experimental work on GQD sensing are understood to play a decisive role in this response, acting as the primary reaction sites for incoming analyte molecules.

The headline result is the sensor’s response to isopropyl alcohol. At a concentration of just 0.8 parts per million, the device produced a response of 29.6 percent at room temperature, a figure the authors describe as exceptional sensitivity. To put that in context, many commercial and laboratory gas sensors require operating temperatures of 150 to 400 degrees Celsius to achieve comparable responses, which means continuous power consumption from an integrated heater. A sensor that works at ambient temperature can run on a battery, which is precisely what a wearable or handheld breath analyser would need. The team also evaluated the sensor against three lung cancer-related VOCs at various ppm concentrations, probing the device’s dynamic range and its limits, and found that the GQD film maintained useful sensitivity across the concentration range relevant to breath analysis.

The researchers frame the work explicitly as an evaluation of sensing limits rather than a demonstration of a finished diagnostic, and that framing is scientifically honest in ways that matter. Real breath contains a complex cocktail of water vapour, carbon dioxide and dozens of interfering VOCs, and any sensor destined for clinical use must discriminate its targets from that background. The study’s systematic testing across multiple compounds and concentrations is a step toward mapping that selectivity landscape, and the strong response to IPA suggests the GQD surface has genuine chemical affinity for alcohol-type molecules. Still, the path from a characterised sensor in a laboratory gas-testing setup to a validated clinical screening tool runs through humid breath samples, patient cohorts and comparison against gold-standard techniques such as gas chromatography-mass spectrometry, which remains the reference method for breath VOC analysis.

Even so, the broader significance of the study is hard to overstate. Lung cancer remains one of the deadliest malignancies worldwide, with global burden estimates projecting continued rises in incidence and mortality through mid-century, and the great majority of cases are detected only after the disease has advanced beyond curable stages. Low-dose CT screening exists but is expensive, resource-intensive and targeted at high-risk populations. A cheap, room-temperature, breath-based sensor would not need to replace CT; it would sit upstream as a triage tool, flagging individuals whose breath chemistry warrants imaging. The authors argue that the combination of precise DFR patterning and the high surface area of their GQDs provides a scalable and cost-effective approach that effectively bridges nanotechnology and point-of-care medical diagnostics, and the numbers they report lend that claim real weight.

What happens next will determine whether graphene quantum dots make the leap from promising laboratory material to the sensing layer in a device that doctors actually use. The immediate research agenda implied by this work includes optimising the functional group chemistry for selectivity, testing long-term stability and drift, and integrating the sensor into arrays that can read patterns of multiple VOCs simultaneously, the approach known as electronic nose sensing. The funding for this study came from India’s RUSA 2.0 programme, with instrumentation support from the G.N. Ramachandran centre at the University of Madras, a reminder that significant sensor research is flourishing well beyond the traditional hubs of Silicon Valley and Western Europe. If the sensing limits mapped here hold up under the harsher conditions of real human breath, the humble graphene quantum dot, a speck of carbon a few nanometres wide, may end up playing an outsized role in catching one of the world’s deadliest cancers while it is still treatable.

Subject of Research: Graphene quantum dot chemiresistive sensors for detecting lung cancer biomarker volatile organic compounds in exhaled breath

Article Title: Evaluating the sensing limits of GQD-based chemiresistive sensor for lung cancer VOC detection

Article References: Ishwariya, P. S. A., Shylaja, R., Kamalarasan, V., Nedumaran, D., & Venkateswaran, C. (2026). Evaluating the sensing limits of GQD-based chemiresistive sensor for lung cancer VOC detection. Journal of Nanoparticle Research, 28(10), Article 255. https://doi.org/10.1007/s11051-026-06758-z

Image Credits: AI Generated

DOI: 10.1007/s11051-026-06758-z

Keywords: graphene quantum dots, chemiresistive gas sensor, lung cancer, volatile organic compounds, breath analysis, isopropyl alcohol, interdigitated electrodes, dry film photoresist, nanosensors, point-of-care diagnostics, room-temperature sensing, pyrolysis-reduction synthesis